Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377) |
---|
04/23/2009 | US20090105361 Camphorquinone Derivative Having Acylphosphine Oxide Group, Photopolymerization Catalyst And Photo/Chemical Polymerization Catalyst Containing The Same And Hardenable Composition Contaning The Same |
04/23/2009 | US20090105279 Tetrahydrofuro[2,3-b]furyl carbamates containing an (oxy)hydrazide group; these compounds target the HIV protease in both wild type and mutant strains of HIV. |
04/23/2009 | US20090105256 Prodrugs of ion channel modulating compounds and uses thereof |
04/23/2009 | US20090104161 Method for activation treatment of antigen-presenting cell |
04/23/2009 | CA2702859A1 Chiral tridentate compounds, corresponding organometal complexes, method for preparing same and use of said compounds and complexes as ligands in asymmetrical catalysis |
04/23/2009 | CA2702829A1 Process for synthesizing phosphonic and phosphinic acid compounds |
04/23/2009 | CA2701037A1 New lipophilic compositions and their uses |
04/22/2009 | EP2050776A1 Polymer having bis(diphenylphosphino)binaphthyl group |
04/22/2009 | EP2050756A1 Phosphorus-containing benzoxazine compound, process for production thereof, curable resin composition, cured article, and laminate plate |
04/22/2009 | EP2050755A1 Supported ionic liquids or activating supports |
04/22/2009 | EP2049554A2 Synthetic lung surfactant and use thereof |
04/22/2009 | EP2049257A1 Process for preparing materials by grafting halogenated phosphorus groups onto an inorganic surface |
04/22/2009 | EP2049201A2 Phosphate diester amides |
04/22/2009 | EP2049200A2 Novel inhibitors of beta-lactamase |
04/22/2009 | EP2049124A2 Phosphorus derivatives as histone deacetylase inhibitors |
04/22/2009 | EP1200455B1 Enzyme catalyzed therapeutic activation |
04/22/2009 | CN101415717A Method for producing aldehyde using bisphosphite and group 8-10 metal compound, and such bisphosphite |
04/22/2009 | CN101415693A Metal complex and use thereof |
04/22/2009 | CN101412735A Preparation of tri(alkoxyphenyl)bismuth compounds |
04/22/2009 | CN101412734A Phosphaphenanthrene-containing small molecular ester compound (ODOPB-DBC) and synthesis technique thereof |
04/22/2009 | CN101412733A Preparation of N-alkyl thiophosphoryl triamide by one-pot method |
04/22/2009 | CN101412732A Trihydrate 3-amino propyl amine ethyl phosphorothioic acid high purity stable crystal and preparation thereof |
04/22/2009 | CN101412731A Preparation of high-purity oil plant lecithin |
04/22/2009 | CN101411976A Method for preparing soya bean lecithin hydrogenation catalyst |
04/22/2009 | CN100481606C Electrolytic solution and battery |
04/22/2009 | CN100481571C Luminescent element material and luminescent element comprising the same |
04/22/2009 | CN100480242C CDK-inhibitory pyrimidines, and production and use thereof as pharmaceutical agents |
04/21/2009 | US7521584 Therapy for ischemic-repefusion injuries; liver disorders; antiarrhythmia agents; anticancer agents; astaxanthin |
04/21/2009 | US7521575 As hydrocyanation catalyst; enables in a simple and economic manner, the hydrocyanation of unsaturated organic compounds with high stability, high reactivity and high selectivity of the catalyst |
04/21/2009 | US7521496 Organophosphorus compound having phosphate-phosphonate bond, and flame-retardant polyester fiber and flame-retardant polyurethane resin composition each containing the same |
04/21/2009 | US7521450 Inhibitors of kinases |
04/21/2009 | US7521436 Modified phosphocalcic compound, injectable composition containing same |
04/21/2009 | US7521141 Organic solution of polyphosphonic acid tetravalent metal salt; easy insertion of particles into pores; high catalytic activity; heat resistance |
04/21/2009 | US7520893 Method for treating neurovascular aneurysms |
04/16/2009 | WO2009048343A1 Functional lipid constructs |
04/16/2009 | WO2009046573A1 Liver targeting adefovir prodrug and its medical use |
04/16/2009 | WO2009023718A3 Novel activators of glucokinase |
04/16/2009 | WO2007069049A3 Processes for the preparation of pure zoledronic acid |
04/16/2009 | WO2006135387A3 Quantum dots tailored with electronically-active polymers |
04/16/2009 | WO2006127627A3 Compostions containing pufa and/or uridine and methods of use thereof |
04/16/2009 | WO2006047507A3 Phosphonate substituted kinase inhibitors |
04/16/2009 | WO2006020573A3 Noncardiotoxic pharmaceutical compounds |
04/16/2009 | US20090099390 Crystalline forms of ibandronic acid and processes for the preparation thereof |
04/16/2009 | US20090099383 Purification of rosuvatatin intermediate by thin film evaporation and chemical method |
04/16/2009 | US20090099381 Optically Active Alpha-Hydroxyphosphonic Acid, Its Derivatives and Production Method thereof, Optically Active Aluminum (Salalen) Complex and Production Method Thereof, and Production Method of Salalen Ligand |
04/16/2009 | US20090099361 chemical vapour deposition (CVD) precursors; precursors for TaN and NbN layers; Ta(NNMe2)Cl3.TMEDA; Nb(NNMe2)Cl3.2Py |
04/16/2009 | US20090099358 Bisphospholanes for use as catalysts in asymmetric reactions |
04/16/2009 | US20090099355 Processes for Production of 4-(Biphenylyl)Azetidin-2-One Phosphonic Acids |
04/16/2009 | US20090099137 Anti-Inflammatory Compounds and Uses Thereof |
04/16/2009 | US20090099136 Dioxolane thymine phosphoramidates as anti-hiv agents |
04/16/2009 | US20090099061 Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics |
04/16/2009 | US20090098589 Method |
04/16/2009 | US20090098221 Creatine ascorbyl derivatives and methods of use thereof |
04/16/2009 | DE112007001391T5 Strahlungsabsorbierende Zusammensetzungen, Verfahren und Gegenstände, die solche Zusammensetzungen einschließen Radiation absorbing compositions, methods and articles that include such compositions |
04/16/2009 | DE102007049015A1 Neue Tantal- und Niob-Verbindungen New tantalum and niobium compounds |
04/16/2009 | CA2702470A1 Functional lipid constructs |
04/15/2009 | EP2048147A1 Phosphorus-containing benzoxazine compound, process for production thereof, curable resin composition, cured article, and laminate plate |
04/15/2009 | EP2048146A2 Novel tantalum and niobium compounds |
04/15/2009 | EP2048143A1 Prodrug of cinnamide compound |
04/15/2009 | EP2048140A1 Deuterated chemiluminescent 1,2-dioxetanes |
04/15/2009 | EP2047534A1 White electroluminescent organic diodes based on molecules derived from phosphole. |
04/15/2009 | EP2046804A1 Synthesis of diethyl{ i5" (3 -fluorophenyl) -pyridine-2-yl] methyl} phosphonate used in the synthesis of himbacine analogs |
04/15/2009 | EP2046792A2 Process for the preparation of tenofovir |
04/15/2009 | EP2046766A1 Agonists of the sphingosine- 1- phosphate receptor (slp) |
04/15/2009 | EP2046757A1 Caspase inhibitors based on pyridazinone scaffold |
04/15/2009 | EP2046746A2 Chemical compounds |
04/15/2009 | EP2046734A1 Derivatives of 4-trimethylammonium-3-aminobutyrate and 4-trimethylphosphonium-3-aminobutyrate as cpt-inhibitors |
04/15/2009 | EP2046714A2 Therapeutic compounds |
04/15/2009 | EP2046342A2 Crystalline form a of ibandronic acid and process for the preparation |
04/15/2009 | EP2003104A9 Reagent for organic synthesis and method of organic synthesis reaction with the reagent |
04/15/2009 | EP1409493B1 Method for producing non-chiral organic compounds containing optically active hydroxy groups |
04/15/2009 | EP1133357B1 Polymer-supported phosphorus ligands for catalysis |
04/15/2009 | CN101410120A 抗炎的膦酸酯化合物 Phosphonate compound anti-inflammatory |
04/15/2009 | CN101407527A Fluoride alkoxycyclotriphosphazene derivative, preparation and use thereof |
04/15/2009 | CN101407444A Method for recovering methyl chloride in discharged tail gas of glyphosate / dimethyl phosphate production |
04/15/2009 | CN100478347C Preparing process adapted for electronic grade solid hydroxyethylidene diphosphonic acid |
04/14/2009 | US7518022 High-quality; suitable as a raw material for cosmetics; good retention of liquidity and is unlikely to become cloudy on change of temperature |
04/14/2009 | US7517868 Phytic citrate compounds and process for preparing the same |
04/14/2009 | US7517858 Prodrugs of pharmaceuticals with improved bioavailability |
04/14/2009 | US7517828 Chiral broensted acid catalyst for asymmetric synthesis and method of asymmetric synthesis with the catalyst |
04/14/2009 | US7517538 Solid supports functionalised with phosphorus dendrimers, method for preparing same and uses thereof |
04/14/2009 | CA2408031C Scale and corrosion inhibitors |
04/14/2009 | CA2374337C Tellurium-containing nanocrystalline materials |
04/14/2009 | CA2182325C Di-substituted 1,2-dioxetane compounds having increased water solubility and assay compositions |
04/09/2009 | WO2009044130A1 Biaryl diphosphines |
04/09/2009 | WO2009043300A1 1,2-disubstituted ruthenocene plane chirality ligand |
04/09/2009 | WO2009043184A1 Nucleotide modular assemblies and their use as delivery devices |
04/09/2009 | WO2009043114A1 Arsenoxide compound and method of use |
04/09/2009 | WO2009021978A3 Compounds containing carbaborane residues and the use thereof in medicine, especially for use in tumour therapy |
04/09/2009 | WO2009020912A3 Mixed fluoroalkyl-alkyl surfactants |
04/09/2009 | WO2008148202A8 Method for the preparation of aminophosphine ligands and their use in metal catalysts |
04/09/2009 | WO2004042784A3 Stabilized semiconductor nanocrystals |
04/09/2009 | US20090093664 Carbon nanotubes using for recovery of radionuclides and separation of actinides and lanthanides |
04/09/2009 | US20090093612 Amide-substituted xanthene dyes |
04/09/2009 | US20090093607 Crosslinked type layered metal phosphonate compound, production process therefor, non-crosslinked type layered metal phosphonate compound, production process therefor, as well as stock solution |
04/09/2009 | US20090093520 Plasma carboxypeptidase b inhibitors |
04/08/2009 | EP2044093A2 Olefin oligomerization catalysts and methods of using same |
04/08/2009 | EP2044092A1 Method for producing organic phosphorous compounds containing halogene |
04/08/2009 | EP2043993A2 Cyclopentane derivatives as antiglaucoma agents |
04/08/2009 | EP2043658A2 Antiviral phosphinate compounds |